HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniele Simoni Selected Research

3- iodoacetylamino- 6- methoxybenzofuran- 2- yl(3,5- trimethoxyphenyl)methanone

4/2013The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniele Simoni Research Topics

Disease

19Neoplasms (Cancer)
11/2020 - 07/2003
5Leukemia
09/2014 - 08/2005
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 10/2009
3Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 07/2008
2Cardiotoxicity
02/2009 - 01/2009
2Breast Neoplasms (Breast Cancer)
02/2009 - 09/2007
2Myeloid Leukemia (Leukemia, Myelocytic)
07/2008 - 01/2004
1Glioblastoma (Glioblastoma Multiforme)
11/2020
1Carcinogenesis
01/2017
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2011
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2009
1Liver Neoplasms (Liver Cancer)
09/2009
1Carcinoma (Carcinomatosis)
10/2008
1Hematologic Neoplasms (Hematological Malignancy)
08/2005
1Lymphoma (Lymphomas)
08/2005
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2004

Drug/Important Bio-Agent (IBA)

7StilbenesIBA
02/2009 - 07/2003
4Imatinib Mesylate (Gleevec)FDA Link
04/2013 - 08/2005
4Pharmaceutical PreparationsIBA
10/2009 - 08/2005
3Proteins (Proteins, Gene)FDA Link
01/2017 - 10/2009
3CurcuminIBA
02/2009 - 09/2007
3cis-3,4',5-trimethoxy-3'-aminostilbeneIBA
02/2009 - 07/2008
3ResveratrolIBA
06/2006 - 07/2003
2IsoxazolesIBA
11/2020 - 09/2007
2Biological ProductsIBA
11/2020 - 06/2010
2hemiasterlinIBA
01/2016 - 08/2012
2Antineoplastic Agents (Antineoplastics)IBA
12/2009 - 02/2009
2Cytotoxins (Cytolysins)IBA
02/2009 - 01/2007
1Temozolomide (Temodar)FDA LinkGeneric
11/2020
1SuspensionsIBA
11/2020
1STAT5 Transcription FactorIBA
01/2016
1MK 2206IBA
01/2016
1Pimozide (Orap)FDA Link
09/2014
13- iodoacetylamino- 6- methoxybenzofuran- 2- yl(3,5- trimethoxyphenyl)methanoneIBA
04/2013
1morpholineIBA
12/2011
1Growth InhibitorsIBA
06/2010
1Tubulin ModulatorsIBA
06/2010
1TubulinIBA
12/2009
1Adenosine Triphosphate (ATP)IBA
10/2009
1Protein Kinases (Protein Kinase)IBA
10/2009
1Oncogene Proteins (Oncogene Protein)IBA
10/2009
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2009
1Tyrosine Kinase InhibitorsIBA
10/2009
1Acetylcysteine (Siran)FDA LinkGeneric
09/2009
1Glutathione (Reduced Glutathione)IBA
09/2009
1Buthionine SulfoximineIBA
09/2009
1PhytochemicalsIBA
02/2009
1Hormones (Hormone)IBA
02/2009
1MorpholinosIBA
01/2009
1ProdrugsIBA
01/2009
1CarbamatesIBA
01/2009
1Bevacizumab (Avastin)FDA Link
01/2009
1ColchicineFDA LinkGeneric
01/2009
1combretastatinIBA
10/2008
1galanginIBA
07/2008
1Estrogen Receptor alphaIBA
09/2007
13'-hydroxypterostilbeneIBA
08/2005
13,3',4,5'-tetrahydroxystilbeneIBA
08/2005
1pterostilbeneIBA
08/2005
1Fas Ligand Protein (Fas Ligand)IBA
08/2005
1RetinoidsIBA
01/2004
13- (4'- hydroxy- 3'- adamantylbiphenyl- 4- yl)acrylic acidIBA
01/2004
1CalciumIBA
01/2004

Therapy/Procedure

7Therapeutics
01/2017 - 07/2008
1Subcutaneous Injections
01/2009